NCT07187011View on ClinicalTrials.gov

Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 1, 2026

Primary Completion Date

March 1, 2029

Study Completion Date

May 1, 2029

Conditions
PTSD - Post Traumatic Stress Disorder
Interventions
DRUG

PT150

Glucorticoid antagonist 900 mg

DRUG

Placebo

900 mg

Trial Locations (2)

77030

Michael E DeBakey VA Medical Center, Houston

92161

Jennifer Moreno Department of VA Medical Center, San Diego

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Pop Test Oncology LLC

INDUSTRY

lead

San Diego Veterans Healthcare System

FED